Back to Browse Journals » Clinical Interventions in Aging » Volume 2 » Issue 4

The many faces of testosterone

Authors Jerald Bain

Published 15 January 2008 Volume 2007:2(4) Pages 567—576

DOI http://dx.doi.org/10.2147/CIA.S1417

Jerald Bain

Department of Medicine, Department of Obstetrics and Gynecology, University of Toronto, Ontario, Canada; Division of Endocrinology and Metabolism, Mount Sinai Hospital, Toronto, Ontario, Canada

Abstract: Testosterone is more than a “male sex hormone”. It is an important contributor to the robust metabolic functioning of multiple bodily systems. The abuse of anabolic steroids by athletes over the years has been one of the major detractors from the investigation and treatment of clinical states that could be caused by or related to male hypogonadism. The unwarranted fear that testosterone therapy would induce prostate cancer has also deterred physicians form pursuing more aggressively the possibility of hypogonadism in symptomatic male patients. In addition to these two mythologies, many physicians believe that testosterone is bad for the male heart. The classical anabolic agents, 17-alkylated steroids, are, indeed, potentially harmful to the liver, to insulin action to lipid metabolism. These substances, however, are not testosterone, which has none of these adverse effects. The current evidence, in fact, strongly suggests that testosterone may be cardioprotective. There is virtually no evidence to implicate testosterone as a cause of prostate cancer. It may exacerbate an existing prostate cancer, although the evidence is flimsy, but it does not likely cause the cancer in the first place. Testosterone has stimulatory effects on bones, muscles, erythropoietin, libido, mood and cognition centres in the brain, penile erection. It is reduced in metabolic syndrome and diabetes and therapy with testosterone in these conditions may provide amelioration by lowering LDL cholesterol, blood sugar, glycated hemoglobin and insulin resistance. The best measure is bio-available testosterone which is the fraction of testosterone not bound to sex hormone binding globulin. Several forms of testosterone administration are available making compliance much less of an issue with testosterone replacement therapy.
Keywords: testosterone, androgens, male hypogonadism, anabolic steroids

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Readers of this article also read:

Psychotherapeutic intervention by telephone

Erika Mozer, Bethany Franklin, Jon Rose

Clinical Interventions in Aging 2008, 3:391-396

Published Date: 6 June 2008

Teriparatide in the management of osteoporosis

Donald Bodenner, Carolyn Redman, Ann Riggs

Clinical Interventions in Aging 2007, 2:499-507

Published Date: 15 January 2008

Testosterone replacement therapy for older men

Stephen E Borst, Thomas Mulligan

Clinical Interventions in Aging 2007, 2:561-566

Published Date: 15 January 2008

Testosterone depot injection in male hypogonadism: a critical appraisal

Aksam A Yassin, Mohamed Haffejee

Clinical Interventions in Aging 2007, 2:577-590

Published Date: 15 January 2008

The stomatognathic system in the elderly. Useful information for the medical practitioner

Anastassia E Kossioni, Anastasios S Dontas

Clinical Interventions in Aging 2007, 2:591-597

Published Date: 15 January 2008

The development of a fear of falling interdisciplinary intervention program

Fernando Gomez, Carmen-Lucia Curcio

Clinical Interventions in Aging 2007, 2:661-667

Published Date: 15 January 2008

Spirituality and well being among elders: differences between elders with heart failure and those without heart failure

Mary T Quinn Griffin, Yi-Hui Lee, Ali Salman, Yaewon Seo, Patricia A Marin, et al

Clinical Interventions in Aging 2007, 2:669-675

Published Date: 15 January 2008

A non-pharmacological intervention to manage behavioral and psychological symptoms of dementia and reduce caregiver distress: Design and methods of project ACT3

Laura N Gitlin, Laraine Winter, Marie P Dennis, Walter W Hauck

Clinical Interventions in Aging 2007, 2:695-703

Published Date: 15 January 2008